Acne treatment and inflammation diminishing externally applied drug and preparation method thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A medicament and anti-acne technology, which is applied in the field of anti-acne and anti-inflammatory external medicaments and its preparation, can solve the problems of long service life, easy to leave acne marks, and large side effects, and achieve the effects of small side effects, reduced water loss, and short treatment course
Inactive Publication Date: 2019-07-26
郑州植美堂生物科技有限公司
View PDF2 Cites 2 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Traditional products have problems such as long service life, slow effect, large side effects, recurrent attacks, and easy to leave acne marks and acne scars
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0050] An external medicament for removing acne and reducing inflammation, comprising the following components in parts by weight:
[0051] 20 parts of deionized water, 10 parts of allantoin glycerin, 50 parts of propylene glycol, 50 parts of ethylhexyl palmitate, 10 parts of glyceryl stearate / PEG-100 stearate, 5 parts of cetearyl glucoside 20 parts, dimethicone 20 parts, cyclopentasiloxane 50 parts, cetearyl alcohol 100 parts, liquid paraffin 10 parts, caprylic / capric triglyceride 20 parts, xanthan gum 10 parts, 20 parts of sodium hyaluronate, 30 parts of hydroxyethyl acrylate / sodium acryloyl dimethyl taurate copolymer, 20 parts of polyisobutylene, 50 parts of PEG-7 trimethylolpropyl coco ether, Chizhi Extract 200 parts, Sophora flavescens extract 100 parts, Salvia miltiorrhiza extract 100 parts, Ligustrum lucidum extract 100 parts, Magnolia officinalis bark extract 100 parts, Rhodiola rosea extract 100 parts, Polygonum multiflorum extract 100 parts, Selaginella 100 parts of...
Embodiment 2
[0062] An external medicament for removing acne and reducing inflammation, comprising the following components in parts by weight:
[0063] 30 parts of deionized water, 8 parts of allantoin glycerin, 45 parts of propylene glycol, 45 parts of ethylhexyl palmitate, 8 parts of glyceryl stearate / PEG-100 stearate, 4.5 parts of cetearyl glucoside Dimethicone 18, Cyclopentasiloxane 45, Cetearyl Alcohol 90, Liquid Paraffin 9, Caprylic / Capric Triglyceride 18, Xanthan Gum 9 parts, 18 parts of sodium hyaluronate, 28 parts of hydroxyethyl acrylate / sodium acryloyl dimethyl taurate copolymer, 18 parts of polyisobutylene, 45 parts of PEG-7 trimethylolpropyl coco ether, Chizhi 180 parts of extract, 90 parts of Sophora flavescens extract, 90 parts of Salvia miltiorrhiza extract, 90 parts of Ligustrum lucidum seed extract, 90 parts of Magnolia officinalis bark extract, 90 parts of Rhodiola rosea extract, 90 parts of Polygonum multiflorum extract, 90 parts of extract, 90 parts of saponins extra...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention belongs to the field of Chinese medicines and particularly relates to an acne treatment and inflammation diminishing externally applied drug and a preparation method thereof. The acne treatment and inflammation diminishing externally applied drug is composed of allantoin glycerin, propylene glycol, ethylhexyl palmitate, glycerol stearate / PEG-100 (polyethylene glycol-100) stearate, cetearyl glucoside, polydimethylsiloxane, cyclopentyl polydimethylsiloxane, cetearyl alcohol, caprylic / capric triglyceride, xanthan gum, sodium hyaluronate, hydroxyethyl acrylate / sodium acryloyldimethyltaurate copolymer, PEG-7 trimethylolpropane coconut ether, ganoderma lucidum extract, radix sophorae flavescentis extract, radix salviae miltiorrhizae extract, fructus ligustri lucidi extract, cortexmagnoliae officinalis extract, herba rhodiolae sacrae extract, radix polygoni multiflori extract, herba selaginellae extract, fructus gleditsiae extract, and aloe vera extract. The acne treatment andinflammation diminishing externally applied drug can not only effectively treat various kinds of pox, acne, eczema and dermatitis, but also is short in treatment cycle, rapid in effect, low in side effect, less prone to recurrence, capable of avoiding acne marks and scars and the like.
Description
technical field [0001] The invention belongs to the field of traditional Chinese medicines, and in particular relates to an externally used medicament for removing acne and reducing inflammation and a preparation method thereof. Background technique [0002] "Acne" is a chronic inflammatory disease of the facial pilosebaceous glands of patients, and is one of the most common diseases in dermatology. If "acne" is not treated in time and effectively, it will affect the appearance of the patient if it is allowed to develop. Its pathogenesis is mainly related to factors such as sex hormone levels, massive secretion of sebaceous glands, proliferation of Propionibacterium acnes, abnormal keratinization of pilosebaceous ducts, and inflammation. [0003] Eczema is a skin inflammatory reaction with severe itching caused by various internal and external factors. . The main cause of the disease is that various factors lead to T lymphocytes contacting allergens to cause type IV aller...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more